Remicade (infliximab) is a prescription drug that’s used to manage certain autoimmune conditions in adults and some children. The drug is usually given as an intravenous (IV) infusion every 8 weeks.

Maintenance doses of the biologic agent infliximab (Remicade) can be safely administered at a patient's home with a very low rate of adverse events (AEs) and serious AEs, according to research ...

Enbrel (etanercept) and Remicade (infliximab) are prescription drugs used to manage certain autoimmune conditions. Enbrel is given as a subcutaneous injection, and Remicade is given as an IV infusion.

June 13, 2006 -- The U.S. Food and Drug Administration (FDA) has approved a 2000-IU (5-mL) dose for antihemophilic factor VIII [recombinant] infusion; and an expanded indication for infliximab ...

Remicade trough levels 2 weeks after infusion were significantly lower in patients with acute severe ulcerative colitis vs. patients with moderately severe ulcerative colitis, according to the results ...

Please provide your email address to receive an email when new articles are posted on . While serologic protection was achieved in only a relatively low proportion of IBD patients on Remicade ...